Purpose Left Ventricular Assist Devices (LVADs) have successfully been established as a treatment for advanced heart failure. However, many areas of the country do not have direct availability to LVAD programs. Therefore, building patient care networks is essential to successful outcomes for patients living in rural areas. The goal of this study is to analyze the effect of distance from an LVAD implanting center on patient survival. Methods We retrospectively analyzed all patients at our center who received HeartMate II LVADs as both “bridge-to transplant” and “destination therapy” from 2008 to 2016, 185 patients were included. Patients were excluded if they: (1) received a transplant, (2) had their LVAD explanted, (3) were transferred to another hospital for care, or (4) failed to reach outpatient status. Patients were then divided into 3 groups based on distance (miles) from their home to the implanting center. Group 1: less than 29, Group 2: between 30 and 120, and Group 3: greater than 120 miles from our implanting center. We then compared survival outcomes at 3, 6, 12, 18, and 24 months on LVAD support. Logistic regression analysis was used to determine statistical significance, p valve Results See Table Conclusion Residential distance from implanting LVAD medical center did not have an adverse effect on the survival outcomes. This supports the notion that a well designed patient care network can provide effective care for patient living remotely from the implanting center.